Hemophilia A: Strategies for Improving Long-Term Holistic Management, Adherence, and Quality of Life

Authors: Escobar, MA; Leissinger, C; Young, G

Affiliations: University of Texas Health Science Center and Gulf States Hemophilia & Thrombophilia Center, Houston, Texas. Louisiana Center for Bleeding and Clotting Disorders New Orleans, Louisiana. Hemostasis & Thrombosis Center, Children’s Hospital Los Angeles, and University of Southern California, Keck School of Medicine, Los Angeles, California.

Publication: Journal of the advanced practitioner in oncology; 2022; 13. 7–20

Abstract: Hemophilia A is a rare inherited bleeding disorder characterized by a deficiency in factor VIII. The evolution of currently approved prophylaxis therapy in hemophilia A will be reviewed, including the clinical value of prophylaxis, real-world experience with prophylaxis, and patient quality-of-life factors that must be considered when choosing treatment options for these patients.